[The chemotherapy of tumors of the central nervous system (author's transl)].
The rational application of chemotherapy in tumors of the central nervous system is discussed in particular the use of the new derivatives of nitrosourea: BCNU (1-3 bis-(2-cloroetil) 1-nitrosourea) and CCNU (cloroetil-cicloesil-nitrosourea). The results of therapy with antimetabolites, alkylating agents, antibiotics, and plant alcaloids, are reported as well as those obtained with radio - sensitizing substances (containing B10 or BUdR, IUdR, FUdR). The results obtained in the United States and in Japan with BCNU and CCNU are considered as well as the personal data of 43 cases treated with BCNU and 10 cases treated with CCNU (including intracranial glial tumors, spinal glial tumors and metastatic tumors of the central nervous system).
D001896:Boron Compounds / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use; D008527:Medulloblastoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009380:Neoplasms, Nerve Tissue / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D013120:Spinal Cord Neoplasms / Q000188:drug therapy
D001896:Boron Compounds; D009607:Nitrosourea Compounds; D008130:Lomustine; D002330:Carmustine; D008727:Methotrexate
La chemioterapia delle neoplasie del sistema nervoso centrale